Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Fred Charatan Two lawsuits have been filed in federal courts in the US states of
California and New Jersey asserting that the Novartis Pharmaceutical Corporation and the American Psychiatric Association conspired to
create a market for methylphenidate (Ritalin), the drug used to treat
hyperactive children, and expand its use.
One of the leading lawyers in the class action suits is Richard
Scruggs, who won a landmark settlement between state attorneys general
and the tobacco industry in 1998. The American Psychiatric Association
would not comment on the lawsuits because it had not yet been served
with the relevant legal documents.
These two new lawsuits come on top of a class action lawsuit launched
in Texas last May by the Dallas law firm Waters and Kraus. The suit
alleged: "Ciba/Novartis planned, conspired, and colluded to create,
develop and promote the diagnosis of Attention Deficit Disorder (ADD)
and Attention Deficit Hyperactivity Disorder (ADHD) in a highly
successful effort to increase the market for its product Ritalin."
It continued: "The American Psychiatric Association (APA)
`conspired, colluded and cooperated with the other Defendants' while taking financial contributions from Ciba as well as other members of
the pharmaceutical industry..."
The defendants "manufactured a disease," asserted Mr Scruggs. "It
has been grossly overprescribed. It is a huge risk."
John Coale, a Washington lawyer who is also involved in the lawsuits,
said that the litigation was brought because Novartis and the
psychiatric group promoted the idea that many children had attention
deficit disorder and attention deficit hyperactivity disorder as a way
of expanding the market for the drug. "They were giving this stuff
away like candy," Mr Coale said.
The association issued a statement in July in response to the Texas
class action lawsuit. It said: "Allegations that the American Psychiatric Association conspired with others to create the diagnoses of Attention Deficit Disorder and Attention Deficit Hyperactivity Disorder as part of its Diagnostic and Statistical Manual (DSM) so that
medication could be used to treat these disorders are ludicrous and
totally false.
"The APA will defend itself vigorously by presenting a mountain of
scientific evidence to refute these meritless allegations, and we are
confident that we will prevail."

(Credit: AP PHOTO/JIM MCKNIGHT)
Kyle Carroll sits with his parents, Jill and Michael, who are
being made to administer Ritalin to him under a court order or lose him
on grounds of neglect. Other parents are now suing psychiatrists for
creating a market for the drug
Read all Rapid Responses